Competitive Advantage

In a Category
of One.

Every competitor either lacks subgingival access, lacks fluorescence detection, or lacks articulation. BioUView is the only device that offers all three — in a single 3.9mm probe.

The Complete Capability Matrix

Every feature that matters — mapped across every competitor.

Capability
BioUView
3.9mm Dual-UV
PerioView
Dental Endoscope
QLF/DIAGNOdent
Surface Scanner
Industrial Scopes
e.g., Vividia
DIAGNOcam
NIR Transillum.
360° Articulation
Sees around corners
Dual-View (Front + Side)
No blind spots
3.9mm Diameter
Pocket/crevice access
Subgingival Access
Reaches where disease lives
405nm Biofilm Detection
Pathogenic biofilm glows red
365nm Structure Mode
Calculus mapping
Implant Thread Visualization
360° around threads
Medical-Grade Validated
Clinical evidence base
NDT Platform Architecture
Industrial precision
Real-Time Documentation
Video capture for records

Head-to-Head Analysis

A direct, evidence-based comparison of BioUView against every alternative in the market.

Dental Endoscope

PerioView

Rigid vs. Articulating. White Light vs. Dual-UV.

Their Limitation

Rigid, front-view only fiber optic probe (~0.5–1mm). White light illumination only. Cannot see around corners. Cannot detect biofilm or calculus by fluorescence.

BioUView Advantage

BioUView's 360° articulating probe sees around every corner. The dual-view cameras eliminate all blind spots. Dual-UV (365nm + 405nm) makes both calculus and pathogenic biofilm visible — capabilities PerioView cannot offer.

Verdict

PerioView provides subgingival access but operates blind to the biological targets. BioUView provides access AND fluorescence detection.

Fluorescence Surface Scanner

QLF / DIAGNOdent

Surface vs. Subgingival.

Their Limitation

Planar, surface-only fluorescence imaging. Cannot access subgingival pockets or implant crevices. Detects caries and surface plaque only. No endoscopic capability.

BioUView Advantage

BioUView takes the same validated fluorescence science and delivers it to the subgingival environment — where the disease actually lives. QLF sees the crown; BioUView sees the pocket.

Verdict

QLF/DIAGNOdent validates the fluorescence approach but cannot reach the most clinically critical sites. BioUView closes this gap entirely.

e.g., Vividia BD-K-3930

Industrial Borescopes

White LED Only. No Clinical Validation.

Their Limitation

Industrial borescopes offer articulation and small diameters but use white LED illumination only. No UV fluorescence. No medical-grade validation. No sterilization protocols for intraoral use.

BioUView Advantage

BioUView applies the same industrial NDT engineering discipline but adds clinically validated dual-UV fluorescence and medical-grade construction. It is the only device that bridges industrial precision and clinical science.

Verdict

Industrial scopes prove the form factor works. BioUView adds the clinical intelligence that makes the form factor clinically meaningful.

Near-Infrared Transillumination

DIAGNOcam

Non-Endoscopic NIR vs. True Subgingival Access.

Their Limitation

Non-endoscopic near-infrared transillumination for caries detection. Excellent for interproximal caries but provides no access to periodontal pockets, implant crevices, or root surfaces.

BioUView Advantage

BioUView's endoscopic design provides true subgingival access for periodontal and implant maintenance — the largest and most underserved clinical indication. DIAGNOcam and BioUView address different problems.

Verdict

DIAGNOcam is a strong caries detection tool. BioUView addresses the periodontal and implant disease burden — a far larger clinical and economic opportunity.

The Market Opportunity

BioUView sits at the intersection of two large, growing markets — and creates a new category that neither currently serves.

~$1.5B
Dental Endoscopy Market
Global, 2025 estimate
~$500M
Dental Fluorescence Diagnostics
Global, 2025 estimate
$200–400M
BioUView Target Capture
10–20% of combined TAM at $4K–$8K ASP